IDiyas

For the Inventor, By the Inventor

Iruma, Japan

Kazuhiro Onogi

USPTO Granted Patents = 16 



Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 43(Granted Patents)


Location History:

  • Saitama, JP (2004)
  • Iruma, JP (1990 - 2011)
  • Higashimurayama, JP (1981 - 2014)

Company Filing History:

goldMedal16 out of 589 
 
Kowa Company Limited
 patents
silverMedal1 out of 8 
 
D. Western Therapeutics Institute, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1981-2014

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8664226 - Compound having 3-heteroarylpyrimidin-4-(3H)-one structure and pharmaceutical preparation containing same (2014-03-04),
2. 7872136 - Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof (2011-01-18),
3. 7858615 - (S)-(-)-1-(4-fluoroisoquinolin-5-Yl)Sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate (2010-12-28),
4. 6806395 - Process for preparation of 3,5-bisalkylphenols (2004-10-19),
5. 6127360 - Diamine derivatives and pharmaceutical containing the same (2000-10-03),
6. 6121286 - Tetrazole derivatives (2000-09-19),
7. 6117886 - Tetrazole derivatives (2000-09-12),
8. 6107308 - Piperidine derivatives (2000-08-22),
9. 6046212 - Chalcone derivatives and drugs containing the same (2000-04-04),
10. 6011033 - Phenylene derivatives (2000-01-04),
11. 5885987 - Phenylene derivatives (1999-03-23),
12. 5756518 - Phenylene derivatives (1998-05-26),
13. 5576324 - Quinoline derivatives or salt thereof and remedy for cardiac diseases (1996-11-19),
14. 5510366 - Indole derivatives, salts thereof, and congestive heart failure (1996-04-23),
15. 4898876 - Benzoylpiperazine esters and a process for their production (1990-02-06),

Title: Kazuhiro Onogi: A Pioneer in Pharmaceutical Innovations

Introduction

Kazuhiro Onogi, based in Iruma, Japan, is a noteworthy inventor with an impressive portfolio of 16 patents. His contributions are particularly significant in the field of pharmaceuticals, where his inventions are aimed at tackling complex health issues.

Latest Patents

Among his latest innovations, Onogi has developed a compound characterized by a 3-heteroarylpyrimidin-4-(3H)-one structure. This compound exhibits both angiotensin-II receptor antagonistic activity and PPARγ activation activity, making it a promising prophylactic and therapeutic agent for a range of health conditions, including hypertension, heart diseases, and type-2 diabetes. Another significant patent includes a process for producing 4-fluoroisoquinoline-5-sulfonyl halide or its salts, which outlines an effective method for synthesis and purification, enhancing efficiency in pharmaceutical production.

Career Highlights

Kazuhiro Onogi has collaborated with notable companies such as Kowa Company Limited and D. Western Therapeutics Institute, Inc. His work in these firms reflects his commitment to pharmaceutical research and innovation, contributing to cutting-edge treatments for various diseases.

Collaborations

In his professional journey, Onogi has collaborated with talented individuals including Masahiro Tamura and Yasushi Wada. These partnerships have enhanced the breadth and impact of his research, allowing for a cumulative exchange of ideas and advancements in the field.

Conclusion

Kazuhiro Onogi stands out as an influential inventor in the realm of pharmaceuticals, with substantial contributions to medical science. His patented innovations, collaborations, and dedication continue to pave the way for new treatments, demonstrating the vital role of inventors in advancing public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…